Results 101 to 110 of about 6,862 (171)

Genetic and Epigenetic Approaches to Opioid Use Disorder. [PDF]

Expert Rev Mol Med
Ranadeva ND, Wijekumar PJ, Fernando CA, Jayamaha AR, Noordeen N, Chackrewarthy S, Fernando N.   +6 more
europepmc   +1 more source

Association between no-shows to scheduled clinic appointments and 30-day risk of overdose in patients prescribed methadone for opioid use disorder. [PDF]

PLoS One
Philofsky HK, Cero I, Maeng DD, Mathis ML.   +3 more
europepmc   +1 more source

The association of methadone use with physical function and frailty among persons who inject drugs. [PDF]

Addiction
Kulik GL, Hsu HY, Rudolph J, Jiang Y, Erlandson KM, Piggott DA, Mehta S, Walston JD, Kirk G, Brown TT, Sun J.   +10 more
europepmc   +1 more source

Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database.

BMJ, 2010
Cornish R, Macleod J, Strang J, Vickerman P, Hickman M.   +4 more
europepmc   +1 more source

Variation in naloxone and buprenorphine prescribing in LA County's safety-net system. [PDF]

J Opioid Manag
Pak L, Crowley C, Ragins K, Belani H, Kalmin M, Watkins KE.   +5 more
europepmc   +1 more source

Opiate substitution treatment in portuguese prisons

, 2009
openaire   +1 more source

FORWARDS-2; study protocol for a double-blind randomised placebo-controlled trial to evaluate baclofen as an adjunct to support methadone detoxification

Paterson LM, Cro S, Loebenberg G, Hazell L, Bagshaw A, Smith C, Lingford-Hughes A.   +6 more
europepmc   +1 more source

Use of Psychoactive Substances Before Incarceration Among Prison Inmates With Drug Abuse or Dependence: Data From the OPPIDUM Program. [PDF]

Fundam Clin Pharmacol
Abbas Z, Lacroix C, Jouve E, Eiden C, Micallef J, Peyrière H, and the French Addictovigilance network.   +6 more
europepmc   +1 more source